MX376501B - Adn huésped como biomarcador de la enfermedad de crohn. - Google Patents

Adn huésped como biomarcador de la enfermedad de crohn.

Info

Publication number
MX376501B
MX376501B MX2017009752A MX2017009752A MX376501B MX 376501 B MX376501 B MX 376501B MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 376501 B MX376501 B MX 376501B
Authority
MX
Mexico
Prior art keywords
subject
host dna
diagnosing
crohn
disease
Prior art date
Application number
MX2017009752A
Other languages
English (en)
Spanish (es)
Other versions
MX2017009752A (es
Inventor
Alessandra Cervino
Original Assignee
Enterome
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterome filed Critical Enterome
Publication of MX2017009752A publication Critical patent/MX2017009752A/es
Publication of MX376501B publication Critical patent/MX376501B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2017009752A 2015-01-30 2016-01-29 Adn huésped como biomarcador de la enfermedad de crohn. MX376501B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15305142 2015-01-30
PCT/EP2016/051989 WO2016120475A1 (en) 2015-01-30 2016-01-29 Host dna as a biomarker of crohn's disease

Publications (2)

Publication Number Publication Date
MX2017009752A MX2017009752A (es) 2017-12-07
MX376501B true MX376501B (es) 2025-03-07

Family

ID=52577797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009752A MX376501B (es) 2015-01-30 2016-01-29 Adn huésped como biomarcador de la enfermedad de crohn.

Country Status (12)

Country Link
US (2) US9873914B2 (enExample)
EP (1) EP3250710B1 (enExample)
JP (1) JP6585175B2 (enExample)
CN (1) CN107208159A (enExample)
AU (1) AU2016211113A1 (enExample)
BR (1) BR112017014978A2 (enExample)
CA (1) CA2973307A1 (enExample)
ES (1) ES2693973T3 (enExample)
IL (1) IL253327B (enExample)
MX (1) MX376501B (enExample)
PL (1) PL3250710T3 (enExample)
WO (1) WO2016120475A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3250710T3 (pl) * 2015-01-30 2019-02-28 Enterome DNA gospodarza jako biomarker choroby Crohna
EP3606325B1 (en) 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
CN112005115A (zh) 2018-02-12 2020-11-27 10X基因组学有限公司 表征来自单个细胞或细胞群体的多种分析物的方法
CN108220286A (zh) * 2018-03-28 2018-06-29 上海锐翌生物科技有限公司 粪便宿主dna甲基化检测方法
CN114882944B (zh) * 2022-06-22 2024-09-20 深圳微伴医学检验实验室 基于Metagenome测序的肠道微生物样品宿主性别鉴定方法、装置及应用
EP4495262A1 (en) 2023-07-21 2025-01-22 Luxia Scientific Host dna as a biomarker of vaginal health

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586177B1 (en) * 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening
CN101238224A (zh) * 2005-06-06 2008-08-06 惠氏公司 炎性肠病的外周血单核细胞的表达谱
RU2313576C1 (ru) * 2006-05-29 2007-12-27 Ростовский-на-Дону научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека РЕКОМБИНАНТНАЯ ПЛАЗМИДА, ЭКСПРЕССИРУЮЩАЯ КЛОНИРОВАННЫЙ ГЕН Ace VIBRIO CHOLERAE И ШТАММ ESCHERICHIA COLI-ПРОДУЦЕНТ ACCESSORY CHOLERAE ENTEROTOXIN VIBRIO CHOLERAE
EP2097540A4 (en) * 2006-11-17 2010-09-01 Genizon Biosciences Inc GENETIC CARD OF HUMAN GENES ASSOCIATED WITH CROHN'S DISEASE
CA2701341C (en) * 2007-11-20 2012-03-20 Johann Karl Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
EP2377883A1 (en) * 2010-04-15 2011-10-19 Universite d'Auvergne Clermont I Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
GB201107466D0 (en) * 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
EP2721173A1 (en) * 2011-06-14 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals
CN103911440B (zh) * 2014-03-13 2015-04-22 南京医科大学 一种与铂类化疗药物肝脏毒性相关的snp标志物及其应用
PL3250710T3 (pl) * 2015-01-30 2019-02-28 Enterome DNA gospodarza jako biomarker choroby Crohna

Also Published As

Publication number Publication date
CA2973307A1 (en) 2016-08-04
WO2016120475A1 (en) 2016-08-04
AU2016211113A1 (en) 2017-09-07
IL253327B (en) 2020-06-30
US10793911B2 (en) 2020-10-06
IL253327A0 (en) 2017-09-28
ES2693973T3 (es) 2018-12-17
EP3250710B1 (en) 2018-08-22
MX2017009752A (es) 2017-12-07
BR112017014978A2 (pt) 2018-03-20
US20180251844A1 (en) 2018-09-06
US20160258017A1 (en) 2016-09-08
CN107208159A (zh) 2017-09-26
JP2018504909A (ja) 2018-02-22
EP3250710A1 (en) 2017-12-06
JP6585175B2 (ja) 2019-10-02
PL3250710T3 (pl) 2019-02-28
US9873914B2 (en) 2018-01-23

Similar Documents

Publication Publication Date Title
MX376501B (es) Adn huésped como biomarcador de la enfermedad de crohn.
MX2016016898A (es) Metodos y composiciones para analisis de muestras.
EP4524255A3 (en) Methods and compositions for nucleic acid analysis
EP4343788A3 (en) Diagnostic methods
WO2016015058A3 (en) Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
EA201892489A1 (ru) Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma)
EP4450636A3 (en) Compositions and methods for enriching populations of nucleic acids
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
BR112017017025A2 (pt) métodos e composições para analizar componentes celulares
EA201792389A1 (ru) Пцр в реальном времени для мультиплексной оптимизированной амплификации с несоответствиями (moma) и для оценки неклеточной днк
EP4219744A3 (en) Methods of preparing nucleic acids for sequencing
MX364812B (es) Método para extraer características morfológicas de una muestra de material biológico.
EA201692157A1 (ru) Синтез двухцепочечных нуклеиновых кислот
EP3101407A4 (en) Protectant for electron microscope observation of hydrated biological sample, kit for electron microscope observation, method for observation, diagnosis, evaluation, or quantification by electron microscope, and sample stage
HK1250171A1 (zh) 使用环化的配对文库和鸟枪测序检测基因组变异的方法
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
MX2018009505A (es) Metodo para determinar helicobacter pylori.
WO2016196993A3 (en) Multi-mediator reagent formulations for use in electrochemical detection
EP3285071A4 (en) Biomarker composition for diagnosing still's disease, diagnostic kit, and diagnostic method
EP4283304A3 (en) Methods of detecting anti-leptin neutralizing antibodies
WO2016012864A3 (en) Biomarkers for anderson-fabry disease
MX2016007148A (es) Metodos de ensayo de beta-glucano.
AU2018273791A1 (en) Biomarker of disease
PT3289096T (pt) Processo para o prognóstico e/ou diagnóstico de uma doença à base de uma amostra de tecido adiposo

Legal Events

Date Code Title Description
FG Grant or registration